IN8bio, Inc. (INAB)
NASDAQ: INAB · IEX Real-Time Price · USD
1.230
+0.020 (1.65%)
Mar 28, 2024, 10:11 AM EDT - Market open

IN8bio Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 20232022202120202019
Selling, General & Admin
13.5114.467.313.182.71
Research & Development
16.8314.067.355.382.36
Other Operating Expenses
-0.330000.07
Operating Expenses
30.0128.5214.658.565.13
Operating Income
-30.01-28.52-14.65-8.56-5.13
Other Expense / Income
---1.780.78
Pretax Income
-30.01-28.52-14.65-10.34-5.91
Net Income
-30.01-28.52-14.65-10.34-5.91
Shares Outstanding (Basic)
30211033
Shares Outstanding (Diluted)
30211033
Shares Change
42.43%110.32%191.59%7.24%-
EPS (Basic)
-1.00-1.36-1.47-3.02-1.85
EPS (Diluted)
-1.00-1.36-1.47-3.02-1.85
Free Cash Flow
-23.94-27.83-13.82-7.13-4.45
Free Cash Flow Per Share
-0.80-1.33-1.39-2.09-1.39
EBITDA
-27.51-27.42-13.87-10.25-5.82
Depreciation & Amortization
2.51.10.790.090.1
EBIT
-30.01-28.52-14.65-10.34-5.91
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).